- Home
- KAR vs ARWR Comparison
KAR vs ARWR Comparison
Compare KAR & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- ARWR
- Stock Information
- Founded
- KAR 2006
- ARWR 2003
- Country
- KAR United States
- ARWR United States
- Employees
- KAR N/A
- ARWR N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- KAR Consumer Discretionary
- ARWR Health Care
- Exchange
- KAR Nasdaq
- ARWR Nasdaq
- Market Cap
- KAR 2.1B
- ARWR 1.7B
- IPO Year
- KAR 2009
- ARWR 1993
- Fundamental
- Price
- KAR $20.13
- ARWR $12.21
- Analyst Decision
- KAR Buy
- ARWR Buy
- Analyst Count
- KAR 5
- ARWR 11
- Target Price
- KAR $22.20
- ARWR $41.44
- AVG Volume (30 Days)
- KAR 912.0K
- ARWR 1.7M
- Earning Date
- KAR 04-30-2025
- ARWR 05-08-2025
- Dividend Yield
- KAR N/A
- ARWR N/A
- EPS Growth
- KAR N/A
- ARWR N/A
- EPS
- KAR 0.45
- ARWR N/A
- Revenue
- KAR $1,788,500,000.00
- ARWR $2,500,000.00
- Revenue This Year
- KAR $1.43
- ARWR $4,380.43
- Revenue Next Year
- KAR $6.78
- ARWR $58.72
- P/E Ratio
- KAR $44.22
- ARWR N/A
- Revenue Growth
- KAR 5.47
- ARWR N/A
- 52 Week Low
- KAR $15.44
- ARWR $12.14
- 52 Week High
- KAR $22.47
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- KAR 46.01
- ARWR 25.33
- Support Level
- KAR $18.87
- ARWR $14.69
- Resistance Level
- KAR $21.42
- ARWR $15.65
- Average True Range (ATR)
- KAR 0.67
- ARWR 0.73
- MACD
- KAR -0.15
- ARWR -0.17
- Stochastic Oscillator
- KAR 49.22
- ARWR 1.75
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.